These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28791405)

  • 1. Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner.
    Sun Y; Guan Z; Zhao W; Jiang Y; Li Q; Cheng Y; Xu Y
    Int J Oncol; 2017 Oct; 51(4):1219-1226. PubMed ID: 28791405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
    Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.
    Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
    Oncol Rep; 2016 Mar; 35(3):1549-56. PubMed ID: 26717965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
    Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
    Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.
    Yousefi M; Ghaffari SH; Zekri A; Hassani S; Alimoghaddam K; Ghavamzadeh A
    Arch Iran Med; 2014 May; 17(5):366-71. PubMed ID: 24784867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
    Tilley C; Deep G; Agarwal C; Wempe MF; Biedermann D; Valentová K; Kren V; Agarwal R
    Mol Carcinog; 2016 Jan; 55(1):3-14. PubMed ID: 25492239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer.
    Kashiwagi E; Ide H; Inoue S; Kawahara T; Zheng Y; Reis LO; Baras AS; Miyamoto H
    Oncotarget; 2016 Aug; 7(31):49169-49179. PubMed ID: 27322140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
    Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
    Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling.
    Long X; Xiong W; Zeng X; Qi L; Cai Y; Mo M; Jiang H; Zhu B; Chen Z; Li Y
    Cell Death Dis; 2019 May; 10(5):375. PubMed ID: 31076571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting silibinin in the antiproliferative pathway.
    Li L; Zeng J; Gao Y; He D
    Expert Opin Investig Drugs; 2010 Feb; 19(2):243-55. PubMed ID: 20047507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
    Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-
    Han C; Wang Z; Chen S; Li L; Xu Y; Kang W; Wei C; Ma H; Wang M; Jin X
    Oxid Med Cell Longev; 2021; 2021():8851763. PubMed ID: 33520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
    Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis.
    Bannwart CF; Nakaira-Takahagi E; Golim MA; de Medeiros LT; Romão M; Weel IC; Peraçoli MT
    Life Sci; 2010 Jun; 86(23-24):880-6. PubMed ID: 20398679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.